Suchergebnisse - "Cantini, Fabrizio"

PubPharm (209)

41

Risk of tuberculosis reactivation associated with traditional disease modifying anti-rheumatic drugs and non-anti-tumor necrosis factor biologics in patients with rheumatic disorders and suggestion for clinical practice

enthalten in: Expert opinion on drug safety | 2019

von Cantini, F. | Niccoli, L. | Capone, A. | +2

42

Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs

enthalten in: Expert review of anti-infective therapy | 2018

von Goletti, D. | Petrone, L. | Ippolito, G. | +3

43

Epidemiology of Psoriasis and Psoriatic Arthritis in Italy-a Systematic Review

enthalten in: Current rheumatology reports | 2018

von Prignano, F. | Rogai, V. | Cavallucci, E. | +3

44

Epidemiology of Psoriasis and Psoriatic Arthritis in Italy—a Systematic Review

enthalten in: Current rheumatology reports | 2018

von Prignano, F. | Rogai, V. | Cavallucci, E. | +3

45

Epidemiology of Psoriasis and Psoriatic Arthritis in Italy—a Systematic Review

enthalten in: Current rheumatology reports | 2018

von Prignano, F. | Rogai, V. | Cavallucci, E. | +3

46

Personalization of biologic therapy in patients with rheumatoid arthritis : less frequently accounted choice-driving variables

enthalten in: Therapeutics and clinical risk management | 2018

von Niccoli, L. | Nannini, C. | Blandizzi, C. | +9

47

Focus on biosimilar etanercept - bioequivalence and interchangeability

enthalten in: Biologics : targets & therapy | 2018

von Cantini, F. | Benucci, M.

48

Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis : A Delphi consensus among Italian experts

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2017

von Armuzzi, A. | Felice, C. | Lubrano, E. | +10

49

Rapid loss of efficacy of biosimilar infliximab in three patients with Behçet's disease after switching from infliximab originator

enthalten in: European journal of rheumatology | 2017

von Cantini, F. | Niccoli, L. | Nannini, C. | +2

50

Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis

enthalten in: Seminars in arthritis and rheumatism | 2017

von Cantini, F. | Niccoli, L. | Nannini, C. | +10